SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-18-002107
Filing Date
2018-03-02
Accepted
2018-03-02 17:07:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A mbvxsc13da_jan162018.htm SC 13D/A 52711
  Complete submission text file 0001654954-18-002107.txt   54136
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60385 | Film No.: 18663135
SIC: 2834 Pharmaceutical Preparations

Mailing Address MABVAX THERAPEUTICS HOLDINGS, INC. 11588 SORRENTO VALLEY ROAD, SUITE 20 SAN DIEGO CA 92121
Business Address
HANSEN JOHN DAVID (Filed by) CIK: 0001186123 (see all company filings)

Type: SC 13D/A